About Pinnacle Life Science
Founded in 2014 as part of the $1.5 billion Aarti Group, Pinnacle Life Science is a leader in the formulation and export of innovative pharmaceutical solutions. Our state-of-the-art manufacturing facilities in Baddi, Himachal Pradesh, have secured US FDA and multiple GMP approvals, enabling us to deliver high-quality medicines globally.
With a diverse portfolio spanning oncology, cardiovascular, anti-infectives, and diabetics, we export to over 90 countries.
Our Mission
Our mission is to lead with purpose, passion, and precision as we aim to:
- Dominate the global pharmaceutical landscape through bold innovation.
- Drive the growth and evolution of life-changing products.
- Foster a culture of excellence, operating with the highest standards of integrity, ethics, and collaboration.
- Relentlessly pursue breakthroughs in R&D, delivering unparalleled customer service and quality at every touchpoint.
Our Vision
We envision a world where healthcare is not only advanced but accessible to all. To achieve this, we are committed to:
- Ensuring consistent, premium quality and timely delivery at competitive prices.
- Adopting cutting-edge technologies that are both cost-effective and safe.
- Providing tailored solutions that adapt to the ever-changing needs of our customers.
- Leveraging the most innovative and flexible manufacturing practices available.
100 M
Oncology oral solid dosage units annually.
3 B
Tablets produced every year.
300 M
Capsules produced every year.
World-Class
Manufacturing Facilities
Our Baddi, Himachal Pradesh facilities are designed with the latest advancements in technology and automation to ensure the highest standards of quality and safety. Recently, our oncology facility received US FDA approval, marking a significant achievement in our journey of global expansion.
Our commitment to innovation and safety is further reflected in the GMP approvals from MCAZ Zimbabwe, DIGEMID Latin America, and other regulatory bodies across the globe.
Driving Innovation through Advanced R&D
Innovation is at the heart of everything we do at Pinnacle Life Science. Our R&D division is equipped with cutting-edge technology, supporting the development of patent non-infringing formulations, modified-release and immediate-release products, and specialized treatments.
With a strong technical team of over 15 scientists holding advanced degrees (M.Pharm and Ph.D.), we are constantly pushing the boundaries of pharmaceutical research to bring innovative healthcare solutions to market.
Our Key Milestones
-
2014
Pinnacle Life Science established as the formulation and export division of Aarti Drugs Limited.
-
2015
Expanded presence to 90+ countries, including regulated and emerging markets.
-
2023
Successfully completed US FDA audit for our Oncology block in April.
-
2023
UK MHRA audit successfully completed in June.
-
2023
Achieved GMP approvals from MCAZ Zimbabwe and DIGEMID Latin America.
-
2024
Launched new products in oncology, cardiovascular, and anti-infective segments.
These milestones mark our continuous progress towards becoming a global leader in pharmaceutical innovation and manufacturing.
A Global Presence Across 90+ Countries
Pinnacle Life Science exports to more than 90 countries, with a strong presence in both regulated and emerging markets, including North America, Europe, Asia, Africa, and Latin America. Our global partnerships ensure that we provide affordable, high-quality healthcare solutions across diverse regions, transforming healthcare systems for the better.
Our top export markets include:
Brazil
Mexico
Pakistan
Turkey
Indonesia
We are proud to collaborate with some of the world’s leading pharmaceutical companies to bring transformative solutions to life.
Explore Our Journey
